DAAM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.87727652604053E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.32933680624592E-12 |
Normal-vs-Stage2 |
1.1265999244614E-10 |
Normal-vs-Stage3 |
7.76319999999942E-05 |
Normal-vs-Stage4 |
1.65903000000078E-05 |
Stage1-vs-Stage2 |
4.653200E-01 |
Stage1-vs-Stage3 |
2.785000E-01 |
Stage1-vs-Stage4 |
9.955800E-01 |
Stage2-vs-Stage3 |
2.052000E-01 |
Stage2-vs-Stage4 |
6.469600E-01 |
Stage3-vs-Stage4 |
5.693800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.78412840057263E-12 |
Normal-vs-AfricanAmerican |
1.67570002318485E-09 |
Normal-vs-Asian |
1.983010E-04 |
Caucasian-vs-AfricanAmerican |
3.552400E-01 |
Caucasian-vs-Asian |
8.256200E-01 |
AfricanAmerican-vs-Asian |
5.704200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.99629999999762E-05 |
Male-vs-Female |
7.032400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.20159999728031E-08 |
Normal-vs-Extreme_Weight |
1.77435843795593E-12 |
Normal-vs-Obese |
1.09619999966171E-07 |
Normal-vs-Extreme_Obese |
1.60069999999291E-06 |
Normal_Weight-vs-Extreme_Weight |
2.348400E-01 |
Normal_Weight-vs-Obese |
7.479000E-01 |
Normal_Weight-vs-Extreme_Obese |
4.704800E-01 |
Extreme_Weight-vs-Obese |
1.060640E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.293000E-01 |
Obese-vs-Extreme_Obese |
4.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.012100E-02 |
Normal-vs-Age(41-60Yrs) |
3.92960000095144E-08 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
8.41799999706794E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.047000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.128200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.357900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.678700E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.772100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.952000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
5.42260003566497E-09 |
Normal-VS-KIRP CIMP |
1.310580E-01 |
Normal-VS-Unclassified PRCC |
3.20040000001409E-06 |
Type1 PRCC-VS-Type2 PRCC |
3.008600E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.393800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.791900E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.063600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.405000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.046600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.88189996919164E-09 |
Normal-vs-N1 |
3.237500E-04 |
Normal-vs-N2 |
1.162320E-03 |
N0-vs-N1 |
9.456400E-02 |
N0-vs-N2 |
9.635200E-01 |
N1-vs-N2 |
4.174400E-01 |
|
|